Fachrepositorium Lebenswissenschaften

13 Treffer

Seiten

Suche

Publisso-Menue

Seiten

Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19

2021 . Javed, Hayate | Meeran, Mohamed Fizur Nagoor | Jha, Niraj Kumar | Ojha, Shreesh

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19

2021 . Smith, Daniel P. | Oechsle, Olly | Rawling, Michael J. | Savory, Ed | Lacoste, Alix M.B. | Richardson, Peter John

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

2021 . Triggle, Chris R. | Bansal, Devendra | Ding, Hong | Islam, Md Mazharul | Farag, Elmoubashar Abu Baker Abd | Hadi, Hamad Abdel | Sultan, Ali A.

Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?

2020 . Rödel, Franz | Arenas, Meritxell | Ott, Oliver J. | Fournier, Claudia | Georgakilas, Alexandros G. | Tapio, Soile | Trott, Klaus-Rüdiger | Gaipl, Udo S.

Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)

2020 . Nadeem, Shahid Muhammad | Zamzami, Mazin A. | Choudhry, Hani | Murtaza, Bibi Nazia | Kazmi, Imran | Shakoori, Abdul Rauf

COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

2020 . Russell, Beth | Moss, Charlotte | Rigg, Anne | Van Hemelrijck, Mieke

COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments

2020 . Zolk, Oliver | Hafner, Susanne | Schmidt, Christoph Q.

The impact of COVID-19 on ischemic stroke

2020 . Zhai, Pan | Ding, Yanbing | Li, Yiming

Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc

2020 . Magro, Giuseppe

Seiten